Neurocrine Biosciences, Inc.
NBIX
$90.93
$0.2050.23%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -12.37% | 18.20% | -14.18% | 17.35% | -5.80% |
| Total Receivables | -0.42% | 2.76% | 3.88% | 2.60% | 5.15% |
| Inventory | 25.33% | 7.76% | 14.25% | -2.87% | 32.99% |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -7.89% | 1.25% | 19.60% | 2.76% | -9.61% |
| Total Current Assets | -8.09% | 12.38% | -7.18% | 11.95% | -2.60% |
|
|
|||||
| Total Current Assets | -8.09% | 12.38% | -7.18% | 11.95% | -2.60% |
| Net Property, Plant & Equipment | 75.51% | -1.66% | -0.90% | -0.35% | 132.15% |
| Long-term Investments | -6.56% | -- | -- | -- | -- |
| Goodwill | -6.56% | -- | -- | -- | -- |
| Total Other Intangibles | 5.80% | 2.99% | -2.33% | -3.38% | 1.72% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -2.82% | 6.83% | 11.23% | 5.59% | -4.67% |
| Total Assets | 5.20% | 6.96% | -4.82% | 6.80% | 14.16% |
|
|
|||||
| Total Accounts Payable | 14.94% | -10.73% | 22.79% | -34.51% | 42.11% |
| Total Accrued Expenses | 18.38% | 18.19% | -17.63% | -3.30% | -6.24% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 16.67% | -1.69% | -77.57% | -7.23% | -9.38% |
| Total Finance Division Other Current Liabilities | 150.00% | -52.17% | -97.17% | 353.20% | -51.22% |
| Total Other Current Liabilities | 150.00% | -52.17% | -97.17% | 353.20% | -51.22% |
| Total Current Liabilities | 18.15% | 7.83% | -44.10% | 8.87% | -5.32% |
|
|
|||||
| Total Current Liabilities | 18.15% | 7.83% | -44.10% | 8.87% | -5.32% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 81.03% | -1.87% | 1.30% | -2.09% | 200.70% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 23.11% | -4.32% | 17.10% | 13.36% | 54.96% |
| Total Liabilities | 38.34% | 2.55% | -26.74% | 6.56% | 20.48% |
|
|
|||||
| Common Stock & APIC | -2.62% | 2.66% | 2.36% | 4.80% | 3.18% |
| Retained Earnings | -64.00% | 266.53% | 57.17% | 27.63% | 48.46% |
| Treasury Stock & Other | -60.00% | 480.00% | -24.24% | -52.86% | 511.76% |
| Total Common Equity | -4.75% | 8.36% | 5.16% | 6.90% | 11.48% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -4.75% | 8.36% | 5.16% | 6.90% | 11.48% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -4.75% | 8.36% | 5.16% | 6.90% | 11.48% |
|
|
|||||
